NCT03519412 2026-03-03ARETHUSAIFOM ETS - The AIRC Institute of Molecular OncologyPhase 2 Completed107 enrolled 14 charts
NCT02178722 2022-02-14Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected CancersIncyte CorporationPhase 1/2 Completed444 enrolled 19 charts